Previous close | 76.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 80.50 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 765 |
Market cap | 214.803M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 13.17 |
EPS (TTM) | N/A |
Earnings date | 15 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
FORESIGHT VCT PLCLEI: 213800GNTY699WHACF4615 April 2024 Final results31 December 2023 Foresight VCT plc, managed by Foresight Group LLP, today announces the final results for the year ended 31 December 2023.These results were approved by the Board of Directors on 15 April 2024. The Annual Report will shortly be available in full at www.foresightgroup.eu. All other statutory information can also be found there. Financial Highlights Total net assets £219.1 million.A final dividend of 4.4p per shar
Foresight VCT PLCLEI: 213800GNTY699WHACF46 Issue of EquityAllotment of Ordinary Shares09 April 2024 The Board of Foresight VCT plc (“the Company”) is pleased to announce that 99,140 Ordinary Shares of 1p each in the capital of the Company (“the Shares”) were allotted on 9 April 2024 pursuant to the offer for subscription (“the Offer”) contained in the prospectus issued by the Company dated 15 November 2023. The Shares were issued at offer prices based on an unaudited net asset value of 86.80 pen
The Board of Foresight VCT Plc (the “Company”) is pleased to announce the successful sale of portfolio company Specac International Limited (“Specac”), a global leader in the manufacture of mass spectroscopy accessories. The transaction generated proceeds of £11.2 million at completion, implying a return of 10.3 times the original investment and an IRR of 34%. Prior to the sale of Specac Limited, the Company’s NAV per ordinary share stood at 85.8p, to which the exit will add 0.6p, giving a pro f